Literature DB >> 346605

Cardiac and renal prostaglandin I2. Biosynthesis and biological effects in isolated perfused rabbit tissues.

P Needleman, S D Bronson, A Wyche, M Sivakoff, K C Nicolaou.   

Abstract

Both the isolated perfused rabbit heart and kidney are capable of synthesizing prostaglandin (PG) I(2). The evidence that supports this finding includes: (a) radiochemical identification of the stable end-product of PGI(2), 6-keto-PGF(1alpha), in the venous effluent after arachidonic acid administration; (b) biological identification of the labile product in the venous effluents which causes relaxation of the bovine coronary artery assay tissue and inhibition of platelet aggregation; and (c) confirmation that arachidonic acid and its endoperoxide PGH(2), but not dihomo-gamma-linolenic acid and its endoperoxide PGH(1), serve as the precursor for the coronary vasodilator and the inhibitor of platelet aggregation. The rabbit heart and kidney are both capable of converting exogenous arachidonate into PGI(2) but the normal perfused rabbit kidney apparently primarily converts endogenous arachidonate (e.g., generated by stimulation with bradykinin, angiotensin, ATP, or ischemia) into PGE(2); while the heart converts endogenous arachidonate primarily into PGI(2). Indomethacin inhibition of the cyclo-oxygenase unmasks the continuous basal synthesis of PGI(2) by the heart, and of PGE(2) by the kidney. Cardiac PGI(2) administration causes a sharp transient reduction in coronary perfusion pressure, whereas the intracardiac injection of the PGH(2) causes an increase in coronary resistance without apparent cardiac conversion to PGI(2). The perfused heart rapidly degrades most of the exogenous endoperoxide probably into PGE(2), while exogenous PGI(2) traverses the heart without being metabolized. The coronary vasoconstriction produced by PGH(2) in the normal perfused rabbit heart suggests that the endoperoxide did not reach the PGI(2) synthetase, whereas the more lipid soluble precursor arachidonic acid (exogenous or endogenous) penetrated to the cyclooxygenase, which apparently is tightly coupled to the PGI(2) synthetase.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 346605      PMCID: PMC372599          DOI: 10.1172/JCI108998

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  32 in total

1.  Unmasking of thromboxane A2 synthesis by ureteral obstruction in the rabbit kidney.

Authors:  A R Morrison; K Nishikawa; P Needleman
Journal:  Nature       Date:  1977-05-19       Impact factor: 49.962

2.  Hormone selective lipase activation in the isolated rabbit heart.

Authors:  W Hsueh; P C Isakson; P Needleman
Journal:  Prostaglandins       Date:  1977-06

3.  Prostaglandins H1 and H2. Convenient biochemical synthesis and isolation. Further biological and spectroscopic characterization.

Authors:  R R Gorman; F F Sun; O V Miller; R A Johnson
Journal:  Prostaglandins       Date:  1977-06

4.  Exaggerated prostaglandin biosynthesis and its influence on renal resistance in the isolated hydronephrotic rabbit kidney.

Authors:  K Nishikawa; A Morrison; P Needleman
Journal:  J Clin Invest       Date:  1977-06       Impact factor: 14.808

5.  The chemical structure of prostaglandin X (prostacyclin).

Authors:  N Whittaker; S Bunting; J Salmon; S Moncada; J R Vane; R A Johnson; D R Morton; J H Kinner; R R Gorman; J C McGuire; F F Sun
Journal:  Prostaglandins       Date:  1976-12

6.  Modulation of human platelet adenylate cyclase by prostacyclin (PGX).

Authors:  R R Gorman; S Bunting; O V Miller
Journal:  Prostaglandins       Date:  1977-03

7.  Cyclic adenosine 3',5'-monophosphate inhibits the availability of arachidonate to prostaglandin synthetase in human platelet suspensions.

Authors:  M Minkes; N Stanford; M M Chi; G J Roth; A Raz; P Needleman; P W Majerus
Journal:  J Clin Invest       Date:  1977-03       Impact factor: 14.808

8.  Effects of prostacyclin (PGX) on cyclic AMP concentrations in human platelets.

Authors:  J E Tateson; S Moncada; J R Vane
Journal:  Prostaglandins       Date:  1977-03

9.  Human arterial and venous tissues generate prostacyclin (prostaglandin x), a potent inhibitor of platelet aggregation.

Authors:  S Moncada; E A Higgs; J R Vane
Journal:  Lancet       Date:  1977-01-01       Impact factor: 79.321

10.  A novel prostaglandin is the major product of arachidonic acid metabolism in rabbit heart.

Authors:  P C Isakson; A Raz; S E Denny; E Pure; P Needleman
Journal:  Proc Natl Acad Sci U S A       Date:  1977-01       Impact factor: 11.205

View more
  28 in total

1.  Rapid inactivation of cyclooxygenase activity after stimulation of intact platelets.

Authors:  E G Lapetina; P Cuatrecasas
Journal:  Proc Natl Acad Sci U S A       Date:  1979-01       Impact factor: 11.205

2.  Triene prostaglandins: prostacyclin and thromboxane biosynthesis and unique biological properties.

Authors:  P Needleman; A Raz; M S Minkes; J A Ferrendelli; H Sprecher
Journal:  Proc Natl Acad Sci U S A       Date:  1979-02       Impact factor: 11.205

3.  Unidirectional transfer of prostaglandin endoperoxides between platelets and endothelial cells.

Authors:  A I Schafer; D D Crawford; M A Gimbrone
Journal:  J Clin Invest       Date:  1984-04       Impact factor: 14.808

4.  Inhibitory action of bradykinin on release of the adrenergic transmitter in the isolated lapine kidney.

Authors:  K U Malik; A Nasjletti
Journal:  Experientia       Date:  1981-05-15

5.  Angiotensin II-induced hypertension in the rat. Effects on the plasma concentration, renal excretion, and tissue release of prostaglandins.

Authors:  D I Diz; P G Baer; A Nasjletti
Journal:  J Clin Invest       Date:  1983-08       Impact factor: 14.808

6.  Reperfusion after acute coronary occlusion in dogs impairs endothelium-dependent relaxation to acetylcholine and augments contractile reactivity in vitro.

Authors:  K M VanBenthuysen; I F McMurtry; L D Horwitz
Journal:  J Clin Invest       Date:  1987-01       Impact factor: 14.808

7.  Prostaglandin formation from exogenous precursor in homogenates of human cardiac tissue.

Authors:  R Brandt; J Nowak; T Sonnenfeld
Journal:  Basic Res Cardiol       Date:  1984 Mar-Apr       Impact factor: 17.165

8.  Attenuation by bradykinin of adrenergically-induced vasoconstriction in the isolated perfused kidney of the rabbit: relationship to prostaglandin synthesis.

Authors:  K U Malik; A Nasjletti
Journal:  Br J Pharmacol       Date:  1979-10       Impact factor: 8.739

9.  Platelet and blood vessel arachidonate metabolism and interactions.

Authors:  P Needleman; A Wyche; A Raz
Journal:  J Clin Invest       Date:  1979-02       Impact factor: 14.808

10.  Shortening of the bleeding time in rabbits by hydrocortisone caused by inhibition of prostacyclin generation by the vessel wall.

Authors:  M A Blajchman; A F Senyi; J Hirsh; Y Surya; M Buchanan; J F Mustard
Journal:  J Clin Invest       Date:  1979-05       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.